Daniel Boer is the founder of ProQR Therapeutics. ProQR Therapeutics has raised $300M in total funding. Latest round: IPO. Based in Leiden, Netherlands.
Daniel de Boer is the Founder and Chief Executive Officer of ProQR Therapeutics, a biopharma company focused on developing RNA editing medicines for genetic diseases. He founded ProQR after his child was diagnosed with a rare disease, with the goal of creating RNA therapies for rare conditions. Under his leadership, the company has built a diversified pipeline and raised over $300 million in funding, including a Nasdaq IPO.
Full founder directory · Investor directory · Company funding database · Fundraising library